|
|
|
|
|
|
|
|
|
|
Rv2043c More about Rv2043c on TBDB.org More about Rv2043c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv2043c: Codons 95 to 99: 12 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Peridgao J MDR 2008 | TAC/TAA | 285 | 95 | Tyr/STOP | 2003 | Portugal | Sequencing | Whole gene | ZHRS | - | MGIT 960 | 48/58 | 1/0 | - | - |
| Lee KW J Korean Med Sci 2001 | AAG/CAG | 286 | 96 | Lys/Gln | 2001 | South korea | Sequencing | Whole gene | Z | - | PZase test with Wayne's method | 92/95 | 1/0 | - | - |
| Marttila HJ AAC 1999 | AAG/GAG | 286 | 96 | Lys/Glu | 1994-1997 | Russia | Sequencing | Whole gene | Z | - | BACTEC 460 | 36/44 | 1/0 | not tested | - |
| Scorpio A AAC 1997 | AAG/ACG | 287 | 96 | Lys/Thr | 1992-1995 | - | PCR-SSCP | Whole gene | Z | >900ug/ml | Pzase testing by Wayne's method | 46/46 | 1/0 | - | - |
| Hirano K TLD 1997 | ins T | 287 | - | Frameshift | 1997 | Canada | Sequencing | Whole gene | ZHRS | >800 | Proportion method | 33/168 | 1/0 | - | - |
| Lee KW J Korean Med Sci 2001 | ins T | 287 | - | Frameshift | 2001 | South korea | Sequencing | Whole gene | Z | - | PZase test with Wayne's method | 92/95 | 1/0 | - | - |
| Scorpio A AAC 1997 | AAG/AAT | 288 | 96 | Lys/Asn | 1992-1995 | - | PCR-SSCP | Whole gene | Z | >900ug/ml | Pzase testing by Wayne's method | 46/46 | 1/0 | - | ![]() |
| Scorpio A Nature Med 1996 | del G | 288 | - | Frameshift | - | USA | Sequencing | Whole gene | Z | >500ug/ml | PZase test with Wayne's method | 39910 | 1/0 | - | - |
| Cheng SJ AAC 2000 | GGT/AGT | 289 | 97 | Gly/Ser | - | USA | Sequencing | Whole gene | ZHRES | >900 | Proportion method, BACTEC 460 | 59/59 | 2/0 | - | ![]() |
| Morlock GP AAC 2000 | GGT/GAT | 290 | 97 | Gly/Asp | 1999 | - | Sequencing | Whole gene | Z | 400 | Proportion method | 37/60 | 1/0 | - | - |
| Hirano K TLD 1997 | TAC/TAA | 297 | 99 | Tyr/STOP | 1997 | Thailand | Sequencing | Whole gene | ZHRSE | >800 | Proportion method | 33/168 | 1/0 | - | - |
| Morlock GP AAC 2000 | TAC/TAG | 297 | 99 | Tyr/STOP | 1999 | - | Sequencing | Whole gene | Z | >800 | Proportion method | 37/60 | 2/0 | - | ![]() |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |